Safety and Efficacy Study of Phenoptin in Subjects With Hyperphenylalaninemia Due to BH4 Deficiency

NCT00355264 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Tetrahydrobiopterin Deficiencies
Hyperphenylalaninemia, Non-Phenylketonuric

Interventions

DRUG: Phenoptin

Sponsor

BioMarin Pharmaceutical